UPDATE: Piper Sandler Assumes Kinnate Biopharma (KNTE) at Overweight
Tweet Send to a Friend
(Updated - May 4, 2021 7:25 AM EDT)
Piper Sandler analyst Christopher Raymond assumes coverage on Kinnate Biopharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Piper Sandler analyst Christopher Raymond assumes coverage on Kinnate Biopharma (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
